Skip to content

Clinical trials

Phase 3 Diabetes Mellitus trials in Peru

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 3 Country / region: Peru Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20045
20067
20081
20098
20101
20131
20141
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda10
Daiichi Sankyo4
AstraZeneca3
GlaxoSmithKline3
Phenomix3
Bristol-Myers Squibb2
Bayer1
Universidad Peruana Cayetano Heredia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus27
Diabetes Mellitus, Type 222
Glucose Metabolism Disorders9
Dyslipidemias7
Hypertension2
Metabolic Diseases2
Acute Coronary Syndrome1
Chronic Disease1
Coronary Artery Disease1
Endocrine System Diseases1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.